Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	11.48B -31.4%
Revenue (ttm)	4.21B +0.6%
Net Income	987.40M -8.4%
EPS	11.61 -8.6%
Shares Out	84.72M
PE Ratio	11.67
Forward PE	9.90
Dividend	7.50 (5.54%)
Ex-Dividend Date	Mar 26, 2025

Volume	760,826
Average Volume	209,753
Open	140.50
Previous Close	141.50
Day's Range	134.50 - 140.50
52-Week Range	133.00 - 244.50
Beta	0.32
RSI	32.46
Earnings Date	Mar 10, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.